Dr. Niamtu appointed to Xeomin Teaching Faculty
The introduction of Botox by Allergan in the 1990’s proved to be a paradigm shift in cosmetic surgery as it was a safe and easy treatment that worked and had no previous type of treatment. Obviously Botox was the first and still the
most popular neurotoxin (now called neuromodulator) with millions of treatments all over the world. Like any industry,
progress introduces competition and several years ago Medicis introduced their product Dysport which although not exactly the same drug as Botox, has the same results. Dysport has caught on and is a popular option for some patients that prefer it to Botox for various reasons, one of them being it is a little less expensive. Dr. Niamtu is recognized as a Key Opinion Leader (KOL) in cosmetic facial surgery and serves on the teaching faculty Botox and Dysport. In addition, he is the only Diamond Level Botox provider in Richmond and the largest solo injector in Virginia (he personally performs all injections).
Dr. Niamtu is proud to be a member of the Xeomin (Merz Aesthetics) teaching faculty. He has recently returned from Berlin, Germany completing instructor training for Xeomin and also had the rare opportunity to tour the actual plant where Xeomin
is produced. He, along with other Key Opinion Leaders in plastic surgery and dermatology, will be teaching Xeomin
injection techniques to physicians in the USA.
Xeomin is the third neuromodulator to be FDA approved in this country and will represent yet another option for patients seeking
improvement of facial wrinkles. Xeomin has been used around the world for safe and effective treatment of facial wrinkles since 1995. Although all these products are technically known as botulinum toxin A, they all have slightly different chemical structures. Xeomin is the first neuromodulator that is processed in a manner to eliminate a part of the molecule known as the accessory protein coat. It is this protein that contributes to allergic reactions. Users of Xeomin can expect the same results as Botox or Dysport although the initial price will probably be less. Otherwise the products are administered the same and have the same results that last the same amount of time. The number of units injected with Xeomin is compatible with Botox injections.
Dr. Niamtu is pleased and honored to be included in the international teaching faculty for Xeomin and is excited to be the first doctor in Richmond to offer this treatment in his practice. Consumers should be prepared for the release of more new neuromodulators that are in the FDA pipeline and just like the different fillers, the multiple neuromodulators will offer more options for patients. For more information about Xeomin or cosmetic
facial surgery visit www.lovethatface.com
Joe Niamtu, III DMD
Cosmetic Facial Surgery